ArticleNanomedicine (London, England)2025

Phospholipid-based nanolipid carriers for dual kinase inhibitors in triple-negative breast cancer.

Nabil K Alruwaili et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.